EDWARD J.

OESTREICHER
4 Stones Throw Road * Easton, Connecticut 06612
203-364-7528 * eo9d7a4e@westpost.net
Executive, Manufacturing Facilities, Materials & Supply Chain Management
Pharmaceutical * Biotech * Medical Device Products
Accomplished at merging leadership, technical expertise and business acumen to c
onsistently deliver pace setting results across all key performance metrics

PROFILE
Dynamic, goal focused and result driven executive with MS and 15+ years of exper
ience leading fully integrated cGMP manufacturing facilities, materials and supp
ly chain management operations that promote growth and profitability for multina
tional enterprises.
Extensive experience in the manufacture and supply of a full range of Pharmaceut
ical, Biotech and unique Medical Device products, internationally.
Adept at leading strategies and business solutions to increase revenues and cata
pult return on investments. Influential change agent with a hands-on, collaborat
ive style; dedicated to holistic problem solving and continuous improvement. Pe
rsonable, articulate and persuasive; trusted business advisor and savvy negotiat
or. Develop "Centers of Excellence" and high-performing teams.
PROFESSIONAL EXPERIENCE
DIRECTOR
Manufacturing and Supply Chain Operations
2009- 2010
International Partnership for Microbicides (IPM)
Bethlehem, Pennsylvania
Directly responsible for all internal and external manufacturing and supply chai
n operations for IPM, reporting to the COO. Supported multiple Phase I - III Cli
nical Trials in the US, Europe and Africa. Direct reports included Process Engin
eering, Procurement, Manufacturing, Packaging, Materials Management / Supply Cha
in and Distribution as well as external CMOs and international logistic service
providers.
Selected Career Accomplishments at IPM:
* Revamped operations significantly reducing costs, improving compliance and ena
bling the cost effective scale up and supply of two new medical devices
* Justified major clean room and manufacturing equipment upgrades to support inc
reased volume required for expanding Phase III for less than 30% of lowest compe
ting CMO bid.
* Successfully passed EU regulatory inspection enabling the release and shipment
of new formulations for clinical trials in various countries.
ASSOCIATE DIRECTOR
Clinical & Commercial Manufacturing, Materials Management
2008 - 2009
MannKind Corporation (Firm recently downsized due to lack of venture capital fun
ding) Danbury, Connecticut
As Head of Materials Management for MannKind Corporation, reporting to the VP of
Manufacturing, provided technical expertise and organizational leadership inclu
ding; short and long range material requirements planning, warehousing, inventor
y control, capacity planning, capital and expense budgeting, procurement and mat
erials handling from receipt through final product distribution. Scope included
a comprehensive cold chain supply program, product development, chemical, clinic
al and commercial manufacturing of drug product and medical devices across three
sites.
Selected Career Accomplishments at MannKind:
* Defined the appropriate infrastructure including people, systems, facilities a
nd equipment in alignment with needs reducing capital and expense spending by 24
%
* Created policies, procedures, standards and metrics to minimize risk, flawless
ly passing ISO 9000, and SOX audits; prepared the site for FDA approval while a
chieving 100% customer service
* Upgraded critical cold chain systems mitigating the loss of multi-million $ in
ventories
* Negotiated new contracts for key materials resulting in a 15% material spend r
eduction
DIRECTOR / TEAM LEADER
Global Manufacturing and Supply Chain Management Division
1995-2007

Pfizer, Incorporated
New York, New York
As a member of the Site Leadership Team for the Division served as internal "co
nsultant" and advisor to senior management and 14 manufacturing sites across the
US, Puerto Rico, Canada and Europe on a variety of continuous improvements in m
anufacturing and supply chain management. Focus areas included; process, qualit
y and cost improvements, capacity analysis, capital investments, fixed and varia
ble asset utilization, sourcing, materials planning and inventory control and ot
her initiatives with primary focus on new product launch strategies, developing
internal and external manufacturing / supply networks, acquisition integration a
nd divestitures.
Served as the primary interface between R&D, Manufacturing and 3 sales divisions
in demand and supply of clinical and commercial materials. Facilitated multiple
project teams driving vital improvements across key performance metrics at majo
r manufacturing sites and distribution centers globally.
Selected Career Accomplishments at Pfizer:
* Orchestrated supply chain mergers of newly-acquired GlaxoSmithKline Animal Hea
lth, Warner Lambert and Pharmacia facilities and multiplied the annual ROI by +7
.6%
* Transformed key sites in the US, Canada, Puerto Rico and Europe into focused c
enters of excellence; secured up to 30% reduction in product costs
* Reduced multibillion-dollar inventory costs by 18% through enhanced budgeting
and category management, which was adopted as a key strategy by Pfizer Inc acros
s all divisions and markets
* Restructured contracts with a strategic partner, which saved $40,000,000 in ca
sh and slashed active ingredient costs by 60% for a large-scale new product laun
ch
* Led the development and implementation of a Global Inventory System (GIS) whic
h consolidated materials inventory data and costs from disparate business system
s providing transparency to all inventories and enabling a $200,000,000 reductio
n in the cost of capital
* Recommended the sale of a mature product line, which increased the profit marg
in by 3% on $1,200,000,000 sales base; facilitated the manufacturing transfer to
the buyer
* Advised against the proposed active pharmaceutical ingredient divestiture and
prevented loss of an annual profit of $84,000,000
* Instituted multi-lingual packaging and innovative stocking methodology that de
creased costs in small markets by 25% and enabled affordable product pricing in
developing countries
* Played a key role in the launch of the industry's 1st global quality managemen
t system that incorporated standards of regulatory agencies worldwide
* Coached new product and supply chain teams integral to the success of scale-up
s and global commercial roll-outs of +10 vaccines and pharmaceutical products
* Advanced from Manager of Manufacturing Support, to Director of Manufacturing S
upport - US Area Manufacturing, prior to being appointed to Team Leader (Directo
r) in Global Supply Chain. Left Pfizer in the wake of patent expiration for maj
or products and ongoing corporate-wide downsizing
OTHER RELEVANT EXPERIENCE
GENERAL MANAGER
1992 - 1995
Ohmeda Pharmaceutical Products N
ottingham, England & Guayama, Puerto Rico
* Directed new product scale-up for the Delta Biotechnology Group in England; ev
aluated and recommended divestiture of commercial production of recombinant huma
n serum albumin (1994-1995)
* As site leader, directly led two facilities with 13 person management team wit
h 348 total associates in all aspects of plant and supply chain management, engi
neering, maintenance, materials planning, logistics, quality, environmental/safe
ty, regulatory compliance, HR and finance. Coordinated a $110,000,000 capital pr
ogram including pilot plant, construction, approvals and startup of API inhalant
anesthetic manufacturing, packaging and warehouse / distribution facilities in
Puerto Rico. Obtained FDA and EMEA approval on first inspection with no observat
ions. (1992-1994)
PLANT MANAGER
1989 - 1992
Bausch & Lomb Pharmaceutical Division
Tampa, Florida
* Integrated 3 acquisitions and oversaw construction, process transfer, approval
and startup of a $60,000,000 manufacturing / distribution complex in launching
a new division for B&L. Directly led three fully integrated manufacturing / supp
ly facilities in New York and Florida, with a workforce of 6 Department Managers
and 440 colleagues that produced aseptic ophthalmic pharmaceuticals
Previous positions include:
Plant Production Manager, Beecham Laboratories (GlaxoSmithKline), New Jersey ? P
ackaging Department Manager, Carter-Wallace, New Jersey ? Technical Director, S
terling Drug - Mexico & New York

EDUCATION
Master of Science (equiv.) in Engineering, Microbiology and Chemistry
University of Cincinnati, Cincinnati, Ohio
Bachelor of Arts in Biology, Minor in Chemistry
Thomas More College, Fort Mitchell, Kentucky